IMMP
Immutep Limited
NASDAQ · Healthcare · Biotechnology · AU
$0.36
−0.05%Next report
Analyst consensus
- Next report date
- Feb 25, 2027
- EPS estimate
- -$0.06
- Revenue estimate
- $2.1M
Latest reported
- Last report date
- Aug 30, 2026
- EPS actual
- -$0.17
- EPS estimate
- -$0.03
- Revenue actual
- $9.9M
- Revenue estimate
- $11.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -128.3%
- Revenue beats (12Q)
- 3
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 25, 2027